Claire H Seedhouse (Claire Seedhouse)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Leukemia & lymphoma

Methods and protocols

Cancer research

University of Nottingham

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nottingham Aug 01 2016

United Kingdom

Associate Professor :: Cancer and Stem Cells

Education History

University of Manchester

United Kingdom

PHD :: Paterson Institute of Cancer Research

Publications

Jenna R James, Johnathan Curd, Jennifer C Ashworth, Mays Abuhantash, Martin Grundy, Claire H Seedhouse, Kenton P Arkill, Amanda J Wright, Catherine L R Merry, Alexander Thompson
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International journal of molecular sciences 24 (4) (2023)
Jenna R James, Johnathan Curd, Jennifer C Ashworth, Mays Abuhantash, Martin Grundy, Claire H Seedhouse, Kenton P Arkill, Amanda J Wright, Catherine L R Merry, Alexander Thompson
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International journal of molecular sciences 24 (4) (2023)
Jenna R James, Johnathan Curd, Jennifer C Ashworth, Mays Abuhantash, Martin Grundy, Claire H Seedhouse, Kenton P Arkill, Amanda J Wright, Catherine L R Merry, Alexander Thompson
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International journal of molecular sciences 24 (4) (2023)
Jenna R James, Johnathan Curd, Jennifer C Ashworth, Mays Abuhantash, Martin Grundy, Claire H Seedhouse, Kenton P Arkill, Amanda J Wright, Catherine L R Merry, Alexander Thompson
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International journal of molecular sciences 24 (4) (2023)
Jenna R James, Johnathan Curd, Jennifer C Ashworth, Mays Abuhantash, Martin Grundy, Claire H Seedhouse, Kenton P Arkill, Amanda J Wright, Catherine L R Merry, Alexander Thompson
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International journal of molecular sciences 24 (4) (2023)
Jenna R James, Johnathan Curd, Jennifer C Ashworth, Mays Abuhantash, Martin Grundy, Claire H Seedhouse, Kenton P Arkill, Amanda J Wright, Catherine L R Merry, Alexander Thompson
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML. International journal of molecular sciences 24 (4) (2023)
Francesco Saverio Tarantini, Siyu Wu, Harry Jenkins, Ana Tellechea Lopez, Hannah Tomlin, Ralph Hyde, Katarzyna Lis-Slimak, Jamie Louise Thompson, Sara Pijuan-Galitó, Danielle Scales, Kazuyo Kaneko, Jayasree Dey, Emily Park, Jack Hill, I-Ning Lee, Lara Doolan, Asta Arendt-Tranholm, Chris Denning, Claire H Seedhouse, Andrew V Benest
Direct RT-qPCR Assay for the Detection of SARS-CoV-2 in Saliva Samples. Methods and protocols 5 (2) (2022)
Martin Grundy, Firas Al-Kaisi, Joanna Cull, Cathy Williams, Dean Smith, Claire H Seedhouse
A same-day assay predicts apoptotic response to combined BCL-2 and MCL-1 BH3-mimetic targeting in multiple myeloma cells. EJHaem 2 (1) (2020)
Hibah Ali Almasmoum, Blessing Airhihen, Claire H Seedhouse, Gerlof Sebastiaan Winkler
Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma. Leukemia & lymphoma 62 (2) (2020)
Hayaa Moeed Alhuthali, Tracey D Bradshaw, Kuan-Hon Lim, Toh-Seok Kam, Claire H Seedhouse
The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun. BMC cancer 20 (1) (2020)
Graham D Bailey, Haitham M H Qutob, Asma Akhtar, Nigel H Russell, Claire H Seedhouse
DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia. British journal of haematology 186 (2) (2019)
Reem Ali, Abdulbaqi Al-Kawaz, Michael S Toss, Andrew R Green, Islam M Miligy, Katia A Mesquita, Claire H Seedhouse, Sameer Mirza, Vimla Band, Emad A Rakha, Srinivasan Madhusudan
Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention. Cancer research 78 (24) (2018)

Claire H Seedhouse.css-eqlu8i{font-size:small;padding-left:4px;} (Claire Seedhouse)

Publication Activity (10 Years)

Top Topics

Top Venues

Claire H Seedhouse (Claire Seedhouse)